ArticleBMJ open2018

Protocol for Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetes Cases (The MAG1C trial): a randomised, double-blinded, placebo-controlled trial.

Nicklas Järvelä Johansen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.